Quantcast
Last updated on April 18, 2014 at 17:08 EDT

Latest Lilly Stories

2014-02-19 08:31:13

-- Ramucirumab Improved Survival in Second-Line Study of Patients with Non-Small Cell Lung Cancer -- INDIANAPOLIS, Feb. 19, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that the REVEL trial, a global Phase III study of ramucirumab in combination with chemotherapy in patients with second-line non-small cell lung cancer (NSCLC), showed a statistically significant improvement in the primary endpoint of overall survival in the ramucirumab-plus-docetaxel arm...

2014-02-05 16:30:56

JourneyEd.com and AcademicSuperStore.com are now under new ownership, and the conjoined education company is making significant changes to its customer experience DALLAS, Feb. 5, 2014 /PRNewswire/ -- JourneyEd.com and AcademicSuperStore.com are now under new ownership. Greg Lamkin is the new CEO, while Tim Lilly fills the role of president, and the consolidated company will be named JourneyEd.com, Inc. Greg Lamkin has been with JourneyEd.com for over 10 years, beginning as a...

2014-02-05 16:27:52

INDIANAPOLIS, Feb. 5, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will participate in the Leerink Swann Global Healthcare Conference on Wednesday, February 12, 2014. Jan M. Lundberg, Ph.D., executive vice president of science and technology and president of Lilly Research Laboratories, will discuss Lilly's pipeline in a fireside chat at 8:25 a.m. EST. A live audio webcast will be available on the Webcasts & Presentations section of Lilly's Investor website at...

2014-01-31 12:25:16

INDIANAPOLIS, Jan. 31, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) has provided the following statement regarding a lawsuit filed by Sanofi in the United States District Court for the District of Delaware alleging patent infringement with respect to LY2963016, a new insulin glargine product for which Lilly is currently seeking approval from the U.S. Food and Drug Administration (FDA). "Lilly respects the intellectual property of others and does not believe the...

2014-01-30 08:29:45

INDIANAPOLIS, Jan. 30, 2013 /PRNewswire/ -- -- Fourth-quarter 2013 revenue declined 2 percent driven by Cymbalta U.S. patent expiration, partially offset by growth in other products. -- Fourth-quarter 2013 earnings per share were $0.67 (reported), or $0.74 (non-GAAP). -- Full-year 2013 revenue increased 2 percent to $23.1 billion. -- Full-year 2013 earnings per share totaled $4.32 (reported), or $4.15 (non-GAAP). -- Approximately $3.8 billion...

2014-01-23 23:29:37

The partnership will raise funds and awareness for the American Diabetes Association throughout the 2014 NASCAR Nationwide Series racing schedule. Houston, TX (PRWEB) January 23, 2014 The NASCAR Nationwide Series race calendar opens up this year, as it usually does, at the Daytona International Speedway, a monument to the history of racing both past and present. This year the race will feature Ryan Reed, an incredibly talented driver who never let his type 1 diabetes diagnosis slow him...

2014-01-07 08:29:50

INDIANAPOLIS, Jan. 7, 2014 /PRNewswire/ -- -- 2014 revenue anticipated to be between $19.2 billion and $19.8 billion. -- Earnings per share for 2014 are expected to be in the range of $2.77 - $2.85, reflecting the impact of patent expirations. -- 2014 net income and operating cash flow goals of $3.0 billion and $4.0 billion, respectively, are expected to be achieved. -- Company reaffirms commitment to maintain dividend at least at current level....

2014-01-07 08:24:59

Secures Financial Stability Sets Next Goal To Increase Endowment To $150 Million Announces New Board Co-Chairs, Maurice Marciano And Lilly Tartikoff Karatz LOS ANGELES, Jan. 7, 2014 /PRNewswire-USNewswire/ -- The Board of Trustees of the Museum of Contemporary Art, Los Angeles (MOCA) announced today that in less than ten months, it has met and exceeded its goal of raising the museum's endowment to an historic high of over $100,000,000, thereby securing independence as the only...

2014-01-02 16:22:13

INDIANAPOLIS, Jan. 2, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its financial guidance for 2014 on Tuesday, January 7, 2014 and, separately, will announce its financial results for the fourth quarter and full year of 2013 on Thursday, January 30, 2014. On each day, Lilly will also conduct conference calls with the investment community and media to further detail the company's 2014 financial guidance and its 2013 financial performance, respectively. The...

2013-12-23 23:24:28

Following an article published by E! Online, which discusses how Evangeline Lilly credits organic food for curing her depression, Colle Farmers Market, an advocate for organic farms, affirms organic food can change lives. Bohemia, NY (PRWEB) December 23, 2013 Colle Farmers Market, a strong advocate for organic farms, comments on an article published by E! Online on December 13th, which details how Evangeline Lilly overcame depression by adopting an organic lifestyle. According to an...